Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. - Wikidata - awgldk - TriplyDB

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

http://www.wikidata.org/entity/Q34397869

about

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices Hypersensitivity Responses in the Central Nervous System Aquaporin-4 autoimmunity Update on biomarkers in neuromyelitis optica B Cells and Autoantibodies in Multiple Sclerosis International consensus diagnostic criteria for neuromyelitis optica spectrum disorders Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases MRI characteristics of neuromyelitis optica spectrum disorder: an international update Treatment of neuromyelitis optica: state-of-the-art and emerging therapies Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort Histopathology and clinical course of MOG-antibody-associated encephalomyelitis Antibody biomarkers in CNS demyelinating diseases - a long and winding road Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Recurrent Longitudinally Extensive Myelitis and Aquaporin-4 Seronegativity - The Expanding Spectrum of Neuromyelitis Optica.MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report.CD19 as a molecular target in CNS autoimmunity.MOG antibody-associated diseases Astrogliosis.A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS.B lymphocytes in neuromyelitis optica TNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune Disease.Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.Clinical and MRI phenotype of children with MOG antibodies Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.

P2860

Q21146662-768A0887-28F1-45D8-A9FE-DA4EA458F792 Q21558554-8FB25DE9-C949-46AA-B303-BFA0A123116B Q26748229-EEFAE414-781A-4EAE-A004-464DE12794AA Q26779177-FF7E8D2D-88D5-4C7F-9427-02240F917C2A Q26799559-30CDC6F9-B830-4E8D-BFD7-7932EB69B451 Q26799789-283AA421-1F66-40E0-A29B-B13100D78556 Q26801386-B7FDFFAF-85D3-40B1-8BED-EDFDA965D63F Q26824579-49190F18-CEF6-4B9A-AB22-827AC6979D01 Q27006941-A75E842C-B47B-4BBD-8A3C-E50692CFEA83 Q28080791-CAFB2355-7CBF-49B0-9EC5-94B0AC738D31 Q28087067-4F85EEAD-1464-44CF-A391-45223725E6A2 Q28245749-B89090C2-8B61-497E-914E-95FB1FC52F00 Q28256650-078B8F06-AF31-43F6-A234-7F08E7B633EB Q28259551-0782B3AF-15FF-473A-9F6B-B1397EC498F4 Q28262403-C2149967-B697-4BD3-B3E9-5C7AEDB53ADC Q28270042-4374E1B7-A8C3-4B01-BD9C-607E08E0C913 Q30371412-31429C3C-0853-4F45-955B-C6770B66A98C Q30833332-566B3178-1C39-4CAF-8BCD-B01156A9BCC8 Q30945169-F3F2E1C4-2972-4921-8945-D863E47994BB Q30975717-984A842A-5CE1-42F8-BFC0-0ED9E5BBFFA6 Q33645795-CC456323-C1E8-4F53-A4F0-ABC8AD48917D Q33741772-8DC74046-A2E6-464A-84D0-D56A55FEBEA6 Q34370104-FDEAD8EC-4424-4D45-B95F-09BA5AC08342 Q34431835-07535FDF-95F1-4149-97A9-107FF6FFA409 Q34453889-1DE702B7-5A88-48C9-AFC3-A3CA12EB2568 Q34486841-55B0962D-10D8-4160-A503-8C3FBD6BEDA2 Q34545836-3141304F-FB39-4F35-98BC-EAC8AEDB5C3F Q34636918-3C44CA10-2FEF-440C-8858-B4B6008DFABB Q34976749-2A669034-FAA2-485E-9D7A-242AD5C65E3B Q35023345-BF849D53-E50D-4965-A46F-5DB012A9452E Q35045104-4E0C3D61-F19A-4187-9051-84F88815AA58 Q35208069-29C06EAA-3459-4F7D-B25B-6EACA335880C Q35208073-8E0190A1-02F5-4011-85EA-ADD6AF82FF13 Q35211076-AD9F15D2-EC8C-46FB-9E07-F81C2F17DA69 Q35591039-8286C3B3-16DC-47A9-9312-EBC98898D336 Q35811308-F7A7B207-B466-4C0F-866B-2C17D680F77E Q36170912-1D3EAA10-8762-4FCD-A737-6D643C3A640E Q36171516-585DD7D6-2E33-457E-BF1B-6ABF995C1276 Q36345618-8B29CC79-4099-4CBF-9E52-B50F6DF4D45D Q36511714-D1960F21-5E79-49E2-A085-13D6BCE1F796

P2860

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

http://www.wikidata.org/entity/Q34397869

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@ast

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@en

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@nl

type

label

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@ast

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@en

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@nl

prefLabel

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@ast

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@en

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@nl

P1433

Q34397869-CE8DEA59-0B8B-4749-83AE-1AA21C64F395

P1476

Q34397869-AAC2E15F-62AE-4C1E-8A56-8B6949C5469B

P2093

Q34397869-1BEF110E-AAFA-4BA8-B7F2-5273E5E5E64C

Q34397869-1D5435E8-6460-483A-BD08-4281D3A7D664

Q34397869-5DBDB7ED-8699-4AA1-9336-AE322CC11A2A

Q34397869-63B868FB-A147-4951-9671-4E2D605AAB37

Q34397869-64AADAE2-FE12-489C-8FAE-DA7C51A5AF43

Q34397869-68C43CCF-F2B3-4724-B6FF-87A340621C82

Q34397869-8A175611-E96B-41DB-9075-F545C9FA462C

Q34397869-CF007099-1690-48D2-9515-2E47A3DB70B4

P304

Q34397869-7E406E10-78E5-4791-83C8-169410CE1D3A

P31

Q34397869-20744B52-9394-423E-98C9-D5F811CAC65C

P356

Q34397869-31FA4615-A2DF-465E-99EA-8F54BD69064A

P407

Q34397869-3787A3F4-8C99-4D34-B2EC-78850B62DC1C

P433

Q34397869-F290B145-E553-45A0-8D94-25A6CFB845D8

P478

Q34397869-C59E9A5B-91F5-49FB-9AB9-76C85D1972E9

P50

Q34397869-50943A4A-CF5A-4DF3-B3FE-E22501B0310C

Q34397869-A930180A-E95F-4A36-8661-F45B2A6FA3CA

P577

Q34397869-6E7035D7-3894-4AD7-AE3E-672D5055A56F

P698

Q34397869-6C05EA2E-D550-4757-AC52-F9354CFF3282

P921

Q34397869-DE1CB01B-56AD-4A94-9DF4-9B9707182E5E

Q34397869-E07C36CE-B49E-45EB-8A0C-CD0FE6656888

P356

JAMANEUROL.2013.5857

P1433

P1476

Neuromyelitis optica spectrum ...... tibodies: a comparative study.

@en

P2093

Andrew Murchison

http://www.w3.org/2001/XMLSchema#string

Jithin George

http://www.w3.org/2001/XMLSchema#string

Joanna Kitley

http://www.w3.org/2001/XMLSchema#string

M Isabel Leite

http://www.w3.org/2001/XMLSchema#string

Mark Woodhall

http://www.w3.org/2001/XMLSchema#string

Patrick Waters

http://www.w3.org/2001/XMLSchema#string

Saleel Chandratre

http://www.w3.org/2001/XMLSchema#string

Wilhelm Küker

http://www.w3.org/2001/XMLSchema#string

P304

276-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMANEUROL.2013.5857

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Jacqueline Palace

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24425068

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte